Filing Analysis
Regulation FD Disclosure
Filed Mar 10, 2026
LOW
vTv Therapeutics Inc. has updated its investor presentation as of March 10, 2026, for use in upcoming meetings with investors and analysts. The presentation was filed under Regulation FD and is available as Exhibit 99.1.
Key Facts
- Updated investor presentation posted to the company website on March 10, 2026
- The presentation will be used for meetings with analysts and other parties
- The filing is made under Item 7.01 Regulation FD Disclosure
- Exhibit 99.1 contains the full investor presentation dated March 2026
Regulation FD Disclosure
Filed Mar 10, 2026
LOW
vTv Therapeutics Inc. announced its financial results for the fiscal year ended December 31, 2025, via a press release on March 10, 2026.
Key Facts
- The company reported financial results for the fiscal year ended December 31, 2025
- The announcement was made through a press release dated March 10, 2026
- The filing was made under Item 2.02 (Results of Operations and Financial Condition)
Regulation FD Disclosure
Filed Feb 26, 2026
LOW
vTv Therapeutics Inc. updated its corporate investor presentation on February 26, 2026, for use in upcoming meetings with investors and analysts. The presentation was filed as an exhibit to comply with Regulation FD requirements.
Key Facts
- The company posted an updated slide presentation to its website on February 26, 2026.
- The presentation is intended for use in meetings with investors, analysts, and other parties.
- The filing was made under Item 7.01 (Regulation FD Disclosure) and includes Exhibit 99.1.
- The presentation is dated February 2026.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.